Академический Документы
Профессиональный Документы
Культура Документы
SUBMITTED BY:
Abhishek katiyar
PGDM (sec.B)
PGD10005
Introduction
History
Started
In
Japanese
Financials
2008-
Growth
of 4%.
North
India
Market
share in India is 5%
Introduction
Japan
Established
Head
Office Tokyo
Leading
drugs.
Workforce
- 29,272 people
Capital - 50 billion yen
History
Sankyo
Established
Daiichi
in 1913
Pharmaceutical
Established
in 1918
In
2006
Started operation of DAIICHI SANKYO HEALTHCARE CO.,
LTD.
April
WHAT IS MERGER
Merger is defined as fusion of two or more
existing
companies.
WHAT IS ACQUISITION
An acquisition is the purchase of a company
by another one by controlling its share capital.
a)Purchase
b)Takeover
RANBAXY-DAIICHI SANKYO
THE DEAL
THE DEAL
Provide
Aim
34.8%
At
Open
THE DEAL
On
valued
In
at $2.4 billion.
Had
Selling
Japanese
Acquisition
Daiichi
Daiichi
EFFECTS ON PHARMA
INDUSTRY
Merger
Ranbaxy 8th largest Generic Drug
Maker in the World
Daiichi Sankyo 25th Largest
Pharmaceuticle Company in the World
After Merger
Ranbaxy Daiichi 15th Largest
Pharmaceutical Company
Ranbaxy to be among the top five
Generic Drug makers in the world
Daiichi:
a Generics Maker
an Innovator
For Ranbaxy
Significant
milestone in becoming a
research-based international
pharmaceutical company.
Ranbaxy
The
For Daiichi
Easier
Conflict
Difficulty
in cultural integration
Monetory
Impact of it on Daiichi
Daichii
Price
Lots
Effect on Indian
Pharmaceutical Industry
Ranbaxy
Hence,
THANK YOU